BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 15916481)

  • 1. Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo.
    Riu E; Grimm D; Huang Z; Kay MA
    Hum Gene Ther; 2005 May; 16(5):558-70. PubMed ID: 15916481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo.
    Miao CH; Thompson AR; Loeb K; Ye X
    Mol Ther; 2001 Jun; 3(6):947-57. PubMed ID: 11407909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo.
    Chen ZY; He CY; Meuse L; Kay MA
    Gene Ther; 2004 May; 11(10):856-64. PubMed ID: 15029228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver.
    Chen ZY; Yant SR; He CY; Meuse L; Shen S; Kay MA
    Mol Ther; 2001 Mar; 3(3):403-10. PubMed ID: 11273783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo.
    Chen ZY; He CY; Ehrhardt A; Kay MA
    Mol Ther; 2003 Sep; 8(3):495-500. PubMed ID: 12946323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX.
    Schüttrumpf J; Milanov P; Abriss D; Roth S; Tonn T; Seifried E
    Hum Gene Ther; 2011 Jan; 22(1):101-6. PubMed ID: 20677911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors.
    Miao CH; Ye X; Thompson AR
    Hum Gene Ther; 2003 Sep; 14(14):1297-305. PubMed ID: 14503965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo.
    Chen ZY; He CY; Kay MA
    Hum Gene Ther; 2005 Jan; 16(1):126-31. PubMed ID: 15703495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
    Van Linthout S; Lusky M; Collen D; De Geest B
    Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extragenic spacer length between the 5' and 3' ends of the transgene expression cassette affects transgene silencing from plasmid-based vectors.
    Lu J; Zhang F; Xu S; Fire AZ; Kay MA
    Mol Ther; 2012 Nov; 20(11):2111-9. PubMed ID: 22565847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation.
    Chen ZY; Riu E; He CY; Xu H; Kay MA
    Mol Ther; 2008 Mar; 16(3):548-56. PubMed ID: 18253155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.
    Mikkelsen JG; Yant SR; Meuse L; Huang Z; Xu H; Kay MA
    Mol Ther; 2003 Oct; 8(4):654-65. PubMed ID: 14529839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of cis-acting elements for gene expression from nonviral vectors in vivo.
    Ehrhardt A; Peng PD; Xu H; Meuse L; Kay MA
    Hum Gene Ther; 2003 Feb; 14(3):215-25. PubMed ID: 12639302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro.
    Miao CH; Ohashi K; Patijn GA; Meuse L; Ye X; Thompson AR; Kay MA
    Mol Ther; 2000 Jun; 1(6):522-32. PubMed ID: 10933977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-Modified Antibiotic Resistance Genes Provide Sustained Plasmid-Mediated Transgene Expression in Mammals.
    Lu J; Zhang F; Fire AZ; Kay MA
    Mol Ther; 2017 May; 25(5):1187-1198. PubMed ID: 28365028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variables affecting in vivo performance of high-capacity adenovirus vectors.
    Schiedner G; Hertel S; Johnston M; Biermann V; Dries V; Kochanek S
    J Virol; 2002 Feb; 76(4):1600-9. PubMed ID: 11799154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eliminating bacteria backbone of naked DNA enhanced hFIX expression and reduced inflammatory response in mice.
    Zhu HZ; Chen HY; Feng DM; Shen Q; Xue JL; Jia W
    Biomed Pharmacother; 2009 Feb; 63(2):129-35. PubMed ID: 18407458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure.
    Zhang G; Song YK; Liu D
    Gene Ther; 2000 Aug; 7(15):1344-9. PubMed ID: 10918507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression.
    Michou AI; Santoro L; Christ M; Julliard V; Pavirani A; Mehtali M
    Gene Ther; 1997 May; 4(5):473-82. PubMed ID: 9274725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
    Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
    J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.